• EN

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    Learn Why The Bull Case For Amplifon (BIT:AMP) Could Change Following Mixed Earnings

    Simply Wall St·11/08/2026 12:30:31
    Listen to the news
    • Amplifon reported third quarter 2026 sales of €575 million and net income of €9.4 million, with nine month sales of €1,760.8 million and net profit of €58.4 million.
    • The mix of higher quarterly earnings but lower nine month profit and earnings per share provides a nuanced view of Amplifon’s current profitability trend.
    • The focus now turns to how this combination of resilient sales and softer nine month earnings may influence Amplifon’s broader investment narrative.

    Scan beyond Amplifon and compare this earnings profile with other mature yet resilient businesses using our curated screener of 223 high quality undervalued stocks, which may offer a similar mix of stability and compression in expectations.

    Amplifon Investment Narrative Recap

    To own Amplifon, you need to be comfortable with a business that relies on steady hearing care demand, margin work through Fit4Growth, and a larger future footprint if the GN Hearing deal proceeds. The latest quarter shows firm sales and a small profit, while the nine-month numbers highlight that profitability is under some pressure.

    In the near term, the key swing factor is whether operating margin work offsets softer earnings and the effect of one-off items, particularly as leverage is set to rise with the planned €2.3b GN Hearing acquisition. The biggest risk remains execution on integration and country mix, rather than this quarter alone.

    The GN Hearing transaction is the main reference point for these results. Management plans to fund it with up to €750m of equity and €1.35b of loans, which would lift net debt and, in turn, make future cash generation and cost control more important if earnings soften again.

    Against that backdrop, this quarter’s modest profit and the weaker nine-month earnings frame how much room Amplifon has to absorb integration costs while still pursuing Fit4Growth savings. For you as a shareholder, the question is whether operational changes and vertical integration through GN Hearing can balance the higher leverage and already elevated P/E multiples.

    Amplifon's narrative projects €3.9b revenue and €350.9 million earnings by 2029, based on expectations of 16.9% yearly revenue growth and an earnings increase of about €275.6 million from €75.3 million today.

    Uncover why Amplifon's fair value indicates a 16% potential upside to its current price that could narrow quickly.

    BIT:AMP 1-Year Stock Price Chart
    BIT:AMP 1-Year Stock Price Chart

    Exploring Other Perspectives

    One alternate view focuses less on hearing care demand and more on the risk that the GN Hearing integration falls short. The most cautious analysts were already working with about €3.8b of 2029 revenue and €302.0 million of earnings, meaning a lower bar than consensus. These pre earnings views could shift as you weigh fresh results against both narratives.

    Explore 3 other Amplifon fair value estimates, including one that suggests there may be as much as 10% downside from the current price.

    Form Your Own Verdict

    Disagree with existing narratives? Extraordinary investment outcomes rarely come from following the herd, so trust your own analysis.

    Looking For More Ideas Beyond Amplifon?

    Once you have a working view on Amplifon, it can help to cross check that thinking against other businesses with different balance sheet strength, risk profiles, or income potential using the Simply Wall St Screener.